Williams Robert
Head of Non-clinical Development Drug Development Office, Cancer Research UK, 61 Lincoln's Inn Fields, WC2A 3PX, London, UK.
Expert Opin Investig Drugs. 2008 Dec;17(12):1791-816. doi: 10.1517/13543780802465737.
This perspective is part of an annual series of papers discussing drugs dropped from clinical development in the previous year. Specifically, this paper focuses on the 28 oncology drugs discontinued in 2007. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I - III clinical trials.